Concepedia

Laia Madrenas

LM

3

Publications

68

Citations

3

H-Index

2022

Active since

Affiliations

Universitat Autònoma de Barcelona(Current)

Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol

Universitat de Vic - Universitat Central de Catalunya

IrsiCaixa

Hospital Clínico Universitario de Valencia

Laia Madrenas is an author at Universitat Autònoma de Barcelona specializing in vaccine safety, precision vaccinology, and clinical trials.

Top concepts

Publications per year

2022–2023

3

Publications

3

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta et al. · The Lancet Regional Health - Europe · 2023 · 31 citations · Full text

Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2

Antonio Barreiro, Antoni Prenafeta, G. Bech-Sàbat et al. · iScience · 2023 · 27 citations · Full text

Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial

Júlia Corominas, Carme Garriga, Antoni Prenafeta et al. · 2022 · 10 citations · Full text

, , +20

Rows per page

1–3 of 3